The pattern of cell death within the AZD6244-treated metastases, suggested that the RAS-MEK pathway was providing a critical survival mechanism under low nutrient and/or hypoxic conditions likely extant within the centers of the bone tumors. Here, MAP2K7 is linked to bone neoplasm.